These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-Sensitized mice. Turcotte R Infect Immun; 1981 Nov; 34(2):315-22. PubMed ID: 6458564 [TBL] [Abstract][Full Text] [Related]
4. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus. Vonberg RP; Mueller M; Emmendoerffer A; Freihorst J Clin Exp Med; 2005 Dec; 5(4):177-83. PubMed ID: 16362797 [TBL] [Abstract][Full Text] [Related]
5. Lymphocyte-macrophage interactions in BCG-treated mice. Florentin I; Bruley-Rosset M; Davigny M Recent Results Cancer Res; 1976; (56):49-57. PubMed ID: 794959 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG. Turcotte R; Legault D Infect Immun; 1986 Mar; 51(3):826-31. PubMed ID: 3081445 [TBL] [Abstract][Full Text] [Related]
7. Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig. van der Meijden AP; de Jong WH; de Boer EC; Steerenberg PA; Debruyne FM; Ruitenberg EJ Urol Res; 1989; 17(1):47-55. PubMed ID: 2922891 [TBL] [Abstract][Full Text] [Related]
8. Negative and positive immunobiological responses in mice pretreated with Bacillus Calmette-Guérin cell wall. Mizushima Y; Wepsic HT; Yamamura Y; DeSilva MA; Janns G; Larson CH Cancer Res; 1984 Jan; 44(1):20-4. PubMed ID: 6228292 [TBL] [Abstract][Full Text] [Related]
9. Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii. Damrow TA; Williams JC; Waag DM Infect Immun; 1985 Jan; 47(1):149-56. PubMed ID: 3965392 [TBL] [Abstract][Full Text] [Related]
10. Effects of BCG on lymphocyte trapping. Zatz MM J Immunol; 1976 Jun; 116(6):1587-91. PubMed ID: 774988 [TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin (BCG) decreases resistance to Listeria monocytogenes infection in mice. Wing EJ Immunology; 1981 Nov; 44(3):509-15. PubMed ID: 7319550 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection. Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942 [TBL] [Abstract][Full Text] [Related]
16. Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin. Klünner T; Bartels T; Vordermeier M; Burger R; Schäfer H Vaccine; 2001 Feb; 19(15-16):1968-77. PubMed ID: 11228367 [TBL] [Abstract][Full Text] [Related]
17. A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice. Petricevich VL; Ueda C; Alves RC; da Silva MA; Moreno C; Melo AR; Dias da Silva W Braz J Med Biol Res; 2001 Jan; 34(1):81-92. PubMed ID: 11151032 [TBL] [Abstract][Full Text] [Related]
18. Active suppression of in vitro reactivity of spleen cells after BCG treatment. Orbach-Arbouys S; Poupon MF Immunology; 1978 Mar; 34(3):431-7. PubMed ID: 305890 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Lagranderie MR; Balazuc AM; Deriaud E; Leclerc CD; Gheorghiu M Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. Bonanni D; Rindi L; Lari N; Garzelli C J Med Microbiol; 2005 May; 54(Pt 5):443-448. PubMed ID: 15824420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]